Faster, better, together: Biopharma collaboration trends in the pandemic and the future of medicine

DATE

October 27, 2021

TIME

10:00 a.m. EDT, 7:00 a.m. PDT, 15:00 BST, 16:00 CEST

Duration: 90 Minutes

Overview

Over the past two years, the COVID-19 pandemic forced the biopharma industry to reckon with new demands and challenges, as researchers raced to develop vaccines in record time. The strategic collaborations born out of this effort offer a trove of insights into the modern bioprocessing world, and how it will change in years to come.

With these and other developments, the therapeutic landscape is evolving rapidly. Companies across the supply chainâ€”from raw materials suppliers to biopharma manufacturersâ€”view collaboration as a critical strategy in all phases from research to production, allowing them to innovate and advance their pipelines.

AGENDA

10:00am - 10:05am

Introduction

Host C&EN

10:05am - 10:15am

The Impact of a Pandemic on Process Development

Justin Moran, PhD, Head of Early Bioprocess Development, Pfizer Vaccines

10:15am - 10:35am

Keynote: A collaborative ecosystem to accelerate the commercial manufacturing of novel vaccines and other therapeutics

Dr. Nandu Deorkar, Vice President, R&D, Biopharma Production, Avantor

10:35am - 10:45am

Lessons on flexibility and scaling-up fast: how the biopharmaceutical industry is preparing to face the next pandemic

Jennifer Grossman, PhD, Business Development Manager, Walter Reed Army Institute of Research Pilot Bioproduction Facility

10:45am - 11:00am

The impact of decentralization and digitization on clinical trial logistics, kits, and sample management

Claudia BerrÃ³n, Senior Vice President, Clinical Services, Avantor

11:00am - 11:10am

Enhanced raw material delivery strategies: Debottlenecking of buffer and media preparation in monoclonal antibodies and novel therapeutics

Dr. Pranav Vengsarkar, Manager Process Development, Research Biopharma, Avantor

11:10am

Q&A

Host C&EN

Brought to you by:

Speakers

Justin Moran, PhD
Head of Early Bioprocess Development,
Pfizer Vaccines

Dr. Nandu Deorkar
Vice President, R&D, Biopharma Production,
Avantor

Jennifer Grossman, PhD
Business Development Manager,
Walter Reed Army Institute of Research Pilot Bioproduction Facility

Claudia BerrÃ³n
Senior Vice President, Clinical Services,
Avantor

Dr. Pranav Vengsarkar
Manager Process Development, Research Biopharma,
Avantor

Kelly McSweeney
Contributing Editor,
C&EN Media Group

Registration

Forwarded this event? Clear the form

Email Address*

Salutation*

First Name*

Last Name*

Company*

Job Title*

Address 1*

City*

State

Zip / Post Code*

Country*

Business Phone*

Are you looking for ways to increase efficiency, flexibility and speed in your manufacturing process?*

Does your company need advice on regulatory uncertainties in the drug development business? *

Would your process benefit from alternative buffer preparation methods to reduce facility footprint, labor hours, and overall cost-of-goods?*

I would like to receive more information on products and services from the American Chemical Society

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

View On Demand Webinars